Bavarian Nordic A/S (CPH:BAVA)
Denmark · Delayed Price · Currency is DKK 184.60
+2.15 (1.18%)
Jul 18, 2025, 4:59 PM CET
Bavarian Nordic Revenue
Bavarian Nordic had revenue of 1.35B DKK in the quarter ending March 31, 2025, with 61.95% growth. This brings the company's revenue in the last twelve months to 6.23B, down -6.18% year-over-year. In the year 2024, Bavarian Nordic had annual revenue of 5.72B, down -19.06%.
Revenue (ttm)
6.23B
Revenue Growth
-6.18%
P/S Ratio
2.31
Revenue / Employee
3.79M
Employees
1,605
Market Cap
14.37B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 303.14B |
| Coloplast | 27.79B |
| Genmab | 22.30B |
| Demant | 22.42B |
| ALK-Abelló | 5.71B |
| H. Lundbeck | 22.95B |
| Ambu A/S | 5.83B |
| Zealand Pharma | 55.69M |
Bavarian Nordic News
- 9 days ago - Bavarian Nordic Enters New Smallpox/Mpox Vaccine Supply Contract with European Country - GlobeNewsWire
- 22 days ago - Bavarian Nordic Announces the Initiation of Clinical Trials of Mpox Vaccine in Infants and Pregnant Women - GlobeNewsWire
- 5 weeks ago - Bavarian Nordic Initiates Phase 3 Study of Chikungunya Vaccine in Children - GlobeNewsWire
- 2 months ago - Bavarian Nordic A/S (BVNKF) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such - GlobeNewsWire
- 2 months ago - Bavarian Nordic A/S 2025 Q1 - Results - Earnings Call Presentation - Seeking Alpha
- 2 months ago - Bavarian Nordic A/S reports interim Q1 results - Seeking Alpha
- 2 months ago - Bavarian Nordic Announces Interim Results for the First Three Months of 2025 - GlobeNewsWire